| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 54.159 | 450 | 747 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 54.322 | 450 | 747 | 0 |
| Total Expenses - EUR | - | - | - | - | - | - | 50.462 | 314 | 217 | 119 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 3.861 | 135 | 530 | -119 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 2.851 | 122 | 454 | -119 |
| Employees | - | - | - | - | - | - | 2 | 0 | 0 | 0 |
Check the financial reports for the company - Lifepharm Market Suport S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 12.598 | 12.736 | 12.486 | 12.298 |
| Current Assets | - | - | - | - | - | - | 18.370 | 107 | 848 | 843 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 3.124 | 0 | 747 | 743 |
| Cash | - | - | - | - | - | - | 15.247 | 107 | 101 | 101 |
| Shareholders Funds | - | - | - | - | - | - | 2.952 | 3.083 | 3.528 | 3.389 |
| Social Capital | - | - | - | - | - | - | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | - | - | 28.016 | 9.760 | 9.806 | 9.753 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Lifepharm Market Suport S.r.l.